🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Ovarii › Georgia › Augusta

Qorannoo klinikaalii Kansarii Ovarii Augusta, GA keessatti

Qorannoo 8 Kansarii Ovarii f Augusta fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Augusta University, Augusta
Umuriin 19 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06586957

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Namoota walitti qabaa jiraSadarkaa 3
  • Georgia Cancer Center, Augusta
Umuriin 18 fi ol · Dubartoota · Haaromfame 15-Ful-2026 · NCT07214779

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Georgia Cancer Center at Augusta University, Augusta
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT06293898

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Namoota walitti qabaa jiraSadarkaa 3
  • Augusta University - Georgia Cancer Center ( Site 0066), Augusta
Umuriin 18 fi ol · Dubartoota · Haaromfame 03-Ful-2026 · NCT06824467

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Augusta University Medical Center, Augusta
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06580314

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Augusta University Georgia Cancer Center, Augusta
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT05579366

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • Georgia Cancer Center at Augusta University, Augusta
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Elb-2026 · NCT05735080

Qorannoo Kansarii Ovarii magaalota biroo keessatti

Qorannoo biroo Augusta keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.